Therapeutic efficacy of rifalazil (KRM-1648) in a M. ulcerans-induced Buruli ulcer mouse model

• Hanako Fukano,

  Roles Data curation, Writing – original draft, Writing – review & editing

  Affiliation Department of Mycobacteriology, Leprosy Research Center, National Institute of Infectious Diseases, Tokyo, Japan

  ⨯
• Kazue Nakanaga,

  Roles Data curation, Investigation

  Affiliation Department of Mycobacteriology, Leprosy Research Center, National Institute of Infectious Diseases, Tokyo, Japan

  ⨯
• Masamichi Goto,

  Roles Data curation, Investigation

  Affiliation Department of Pathology, Field of Oncology, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan

  https://orcid.org/0000-0003-0943-4115

  ⨯
• Mitsunori Yoshida,

  Roles Investigation, Methodology

  Affiliation Department of Mycobacteriology, Leprosy Research Center, National Institute of Infectious Diseases, Tokyo, Japan

  ⨯
• Norihisa Ishii,

  Roles Data curation

  Affiliations Department of Mycobacteriology, Leprosy Research Center, National Institute of Infectious Diseases, Tokyo, Japan, National Sanatorium Tamazenshoen, Tokyo, Japan

  ⨯
• Yoshihiko Hoshino

  Roles Conceptualization, Funding acquisition, Supervision, Writing – original draft, Writing – review & editing

  * E-mail: yhoshino@nih.go.jp

  Affiliation Department of Mycobacteriology, Leprosy Research Center, National Institute of Infectious Diseases, Tokyo, Japan

  https://orcid.org/0000-0002-3132-0715

  ⨯